Medical technology company, IRIDEX Corporation, is making waves in the field of ophthalmology with its range of laser systems, delivery devices, and consumable instrumentation. Offering an array of options including the Cyclo G6 laser system for glaucoma treatment, the IQ 532 and IQ 577 for the treatment of retinal disorders, and the OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems for treating conditions like proliferative diabetic retinopathy and retinal tears, the company is providing solutions to a range of sight-threatening diseases. Additionally, IRIDEX offers delivery devices such as the TxCell scanning laser delivery system, slit lamp adapter, and laser indirect ophthalmoscope. The company also provides the MicroPulse P3 Probe for performing MicroPulse transscleral laser therapy, the G-Probe for treating uncontrolled glaucoma, and the EndoProbe for vitrectomy procedures. Along with serving ophthalmologists, the company markets its products through direct and independent sales forces within the United States and independent distributors globally. IRIDEX Corporation's headquarters are located in Mountain View, California, and the company was incorporated in 1989, previously known as IRIS Medical Instruments, Inc. before changing its name to IRIDEX Corporation in November of 1995.
IRIDEX's ticker is IRIX
The company's shares trade on the NASDAQ stock exchange
They are based in Mountain View, California
There are 51-200 employees working at IRIDEX
It is iridex.com
IRIDEX is in the Healthcare sector
IRIDEX is in the Medical Appliances & Equipment industry
The following five companies are IRIDEX's industry peers: